Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Merck Sharp & Dohme LLC
Toni K Choueiri; Piotr Tomczak; Se Hoon Park; Balaji Venugopal; Thomas Ferguson; Yen-Hwa Chang; Jaroslav Hajek; Stefan N Symeonides; Jae Lyun Lee; Naveed Sarwar; Antoine Thiery-Vuillemin; Marine Gross-Goupil; Mauricio Mahave; Naomi B Haas; Piotr Sawrycki; Howard Gurney; Christine Chevreau; Bohuslav Melichar; Evgeniy Kopyltsov; Ajjai Alva; John M Burke; Gurjyot Doshi; Delphine Topart; Stephane Oudard; Hans Hammers; Hiroshi Kitamura; Jens Bedke; Rodolfo F Perini; Pingye Zhang; Kentaro Imai; Jaqueline Willemann-Rogerio; David I Quinn; Thomas Powles; KEYNOTE-564 Investigators